title: Variable expression of the Fragile X Mental Retardation 1 (FMR1) gene in patients with premature ovarian failure syndrome is not dependent on number of (CGG)n triplets in exon 1.
abstract: BACKGROUND
  Increased expression of the Fragile X Mental Retardation 1 (FMR1) gene in blood cells has been claimed to be associated with variable (CGG)(n) triplet numbers in the 5' untranslated region of this gene. Increased CGG triplet numbers, including that of the so-called premutation range (n= 55-200), were shown to have a risk of <26% to impair ovarian reserve leading to primary ovarian insufficiency and premature ovarian failure (POF).
  
  
  METHODS
  DNA and RNA samples were isolated from 74 patients with idiopathic POF to evaluate quantitatively the expression of FMR1 in leukocytes and CGG triplet number on FMR1 gene alleles. mRNA levels were normalized and compared with those of control women. Expression of the encoded protein (FMRP) was analysed by immunohistochemistry on ovarian biopsy tissue sections.
  
  
  RESULTS
  A large variance of the FMR1 transcript level was found in the leukocyte RNA samples, but only in patients with POF, and this variability did not correlate to variance of CGG triplet numbers found on both FMR1 alleles (19 < n > 90). During normal folliculogenesis, FMRP is predominantly expressed in granulosa cells.
  
  
  CONCLUSIONS
  Our data suggest that FMR1 expression during human folliculogenesis is probably a quantitative trait. Proper function of FMRP in granulosa cells seems to depend on an optimal transcript level. All women with CGG triplet numbers outside the range associated with normal folliculogenesis (26 < n > 34) are therefore expected to have a relaxed FMR1 transcription control. FMR1 transcript levels in leukocytes might therefore be diagnostic for altered FMRP levels in granulosa cells, which will affect the process of folliculogenesis.
authors.affiliation: Department of Gynecology Endocrinology, University Women Hospital, Heidelberg, Germany.
authors.forename: J
authors.initials: J
authors.lastname: Schuettler
authors.forename: Z
authors.initials: Z
authors.lastname: Peng
authors.forename: J
authors.initials: J
authors.lastname: Zimmer
authors.forename: P
authors.initials: P
authors.lastname: Sinn
authors.forename: C
authors.initials: C
authors.lastname: von Hagens
authors.forename: T
authors.initials: T
authors.lastname: Strowitzki
authors.forename: P H
authors.initials: PH
authors.lastname: Vogt
mesh_terms: D020121:5' Untranslated Regions; D000328:Adult; D005091:Exons; D005260:Female; D051860:Fragile X Messenger Ribonucleoprotein 1 / Q000235:genetics / Q000378:metabolism*; D014644:Genetic Variation; D006107:Granulosa Cells / Q000502:physiology; D006801:Humans; D007962:Leukocytes / Q000378:metabolism; D008875:Middle Aged; D006080:Ovarian Follicle / Q000254:growth & development; D016649:Primary Ovarian Insufficiency / Q000235:genetics*; D012333:RNA, Messenger / Q000378:metabolism; D012307:Risk Factors; D017422:Sequence Analysis, DNA
chemical_list: D020121:5' Untranslated Regions; D051860:Fragile X Messenger Ribonucleoprotein 1; D012333:RNA, Messenger; C497683:FMR1 protein, human